关注
Briann Fischetti
Briann Fischetti
Associate Professor of Pharmacy Practice, LIU Pharmacy
在 liu.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Real-world experience with higher-than-recommended doses of lamivudine in patients with varying degrees of renal impairment
B Fischetti, K Shah, DR Taft, L Berkowitz, A Bakshi, A Cha
Open Forum Infectious Diseases 5 (10), ofy225, 2018
222018
Serological response with Heplisav-B® in prior hepatitis B vaccine non-responders living with HIV
R Khaimova, B Fischetti, R Cope, L Berkowitz, A Bakshi
Vaccine 39 (44), 6529-6534, 2021
212021
Evaluation of virologic suppression rates during the COVID‐19 pandemic with outpatient interdisciplinary HIV care
M Sorbera, B Fischetti, R Khaimova, M Niewinski, K Wen
Journal of the American College of Clinical Pharmacy 4 (8), 964-968, 2021
192021
Outpatient management of chronic warfarin therapy at a pharmacist-run anticoagulation clinic during the COVID-19 pandemic
R Cope, B Fischetti, N Eladghm, M Elaskandrany, N Karam
Journal of Thrombosis and Thrombolysis, 1-5, 2021
162021
Safety and efficacy of weight‐loss pharmacotherapy in persons living with HIV: a review of the literature and potential drug‐drug interactions with antiretroviral therapy
RJ Cope, BS Fischetti, RK Kavanagh, TM Lepa, MA Sorbera
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (12 …, 2019
142019
The role of antisense therapies targeting lipoprotein (a)
R Plakogiannis, M Sorbera, B Fischetti, M Chen
Journal of Cardiovascular Pharmacology 78 (1), e5-e11, 2021
122021
The impact of escape room gamification using a teleconferencing platform on pharmacy student learning
A Gerber, B Fischetti
Medical Science Educator 32 (5), 1159-1164, 2022
112022
Using PBPK modeling to predict drug exposure and support dosage adjustments in patients with renal impairment: an example with lamivudine
K Shah, B Fischetti, A Cha, DR Taft
Current Drug Discovery Technologies 17 (3), 387-396, 2020
72020
Evaluation of rates of virologic suppression in HIV-positive patients with varying numbers of comorbidities
B Fischetti, M Sorbera, R Michael, N Njeim
American Journal of Health-System Pharmacy 79 (2), 72-77, 2022
52022
Prescriber attitudes toward implementation of pharmacogenomic testing in a family medicine residency program
A Gallipani, R Cope, B Fischetti, S Abraham, A Ankireddypalli
PRiMER: Peer-Review Reports in Medical Education Research 2, 2018
52018
Use of lidocaine cream for pain management during immunizations of infants at an urban health clinic
T Lepa, M Valentine, AO Alshehry, EP Morgan, K Sessa, B Fischetti
Journal of pharmacy practice 35 (6), 911-915, 2022
32022
Evaluation of the Use of Social Media and Virtual Meeting Platforms in the Pursuit of Pharmacy Residency Training
BS Fischetti, C Ciaramella, EM Kim, IC Papamanolis
Journal of Pharmacy Practice 36 (5), 1072-1076, 2023
12023
Glycemic Control in Patients Living With HIV Initiated on Integrase Inhibitor–Based Three-Drug Antiretroviral Therapy
A Gerber, B Fischetti, O Popova, M Longo
Journal of Pharmacy Technology 40 (2), 85-91, 2024
2024
Evaluation of Teaching Activities Completed by PGY2 Pharmacy Residents at Colleges of Pharmacy
B Fischetti, T Amin, W Chen
Medical Science Educator 33 (6), 1487-1492, 2023
2023
Evaluation of rates of virologic suppression in HIV-positive patients with varying numbers of comorbidities (vol 79, pg 72, 2022)
B Fischetti, M Sorbera, R Michael, N Njeim
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY 79 (9), E103-E103, 2022
2022
Optimization of SGLT2 Inhibitor Use in Patients with Diabetes and Heart Failure with Reduced Ejection Fraction
N Greco, R Quinn, B Fischetti
2021 ACCP Virtual Poster Symposium (May 25 and 26), 2021
2021
Outpatient Management of Human Immunodeficiency Virus during COVID-19 Pandemic
M Sorbera, B Fischetti, M Niewinski, K Wen
2020 ACCP VIRTUAL Annual Meeting (October 19-30), 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–17